GENEVA, June 19 -- FIDIA FARMACEUTICI S.P.A. filed a patent application (IB2025/061506) for “NEW MOLECULES AND THEIR USE IN THE TREATMENT OF PATHOLOGIES RELATED TO OXIDATIVE STRESS”. With publication no. WO/2026/104986, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 47/55
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....